The molecular mechanisms that enable and mediate cell type-specific transcriptional responses to intracellular and extracellular cues remain poorly understood. Early experiments indicated that sequences far away from gene promoters are often required to regulate cell type-specific transcription 1 . Such genetic elements are termed enhancers and were initially functionally defined as DNA sequences that have the potential to enhance basal transcription levels from gene promoters and transcriptional start sites (TSSs) 1 at distances ranging from hundreds of bases to megabases 2 . Recent genome-wide transcription factor-binding studies indicated that the majority of transcription factor binding sites are found in distal locations that frequently exhibit enhancer function 3-9 , which is consistent with the profound role of enhancers in shaping signal-dependent transcriptional responses [10] [11] [12] . When cell signalling induces an increase in the nuclear concentration and DNA binding of transcription factors, as occurs following the activation of steroid hormone receptors and nuclear factor-κB (NF-κB), the great majority of binding events typically occur at genomic locations that already exhibit enhancer-like histone modifications and binding of other transcription factors 5, 6 . As the complement of active cis-regulator y elements is different across cell types, these findings introduced the notion that pre-existing sets of enhancers are primarily responsible for cell type-specific gene expression and responses to external stimul i [13] [14] [15] . The annotation of epigenetic features that are associated with enhancers in many different cell lines, primary cells and tissues by the Encyclopedia of DNA Elements (ENCODE) consortium provided evidence for the use of several hundreds of thousands of such elements in the human genome 16 , which greatly exceeds the number of genes that encode mRNAs or long intergenic noncoding RNAs (lincRNAs). This raised the question of how the correct subsets of enhancers are selected from the large repertoire of potential enhancers in each particula r cell type.
The molecular mechanisms that enable and mediate cell type-specific transcriptional responses to intracellular and extracellular cues remain poorly understood. Early experiments indicated that sequences far away from gene promoters are often required to regulate cell type-specific transcription 1 . Such genetic elements are termed enhancers and were initially functionally defined as DNA sequences that have the potential to enhance basal transcription levels from gene promoters and transcriptional start sites (TSSs) 1 at distances ranging from hundreds of bases to megabases 2 . Recent genome-wide transcription factor-binding studies indicated that the majority of transcription factor binding sites are found in distal locations that frequently exhibit enhancer function [3] [4] [5] [6] [7] [8] [9] , which is consistent with the profound role of enhancers in shaping signal-dependent transcriptional responses [10] [11] [12] . When cell signalling induces an increase in the nuclear concentration and DNA binding of transcription factors, as occurs following the activation of steroid hormone receptors and nuclear factor-κB (NF-κB), the great majority of binding events typically occur at genomic locations that already exhibit enhancer-like histone modifications and binding of other transcription factors 5, 6 . As the complement of active cis-regulator y elements is different across cell types, these findings introduced the notion that pre-existing sets of enhancers are primarily responsible for cell type-specific gene expression and responses to external stimul i [13] [14] [15] . The annotation of epigenetic features that are associated with enhancers in many different cell lines, primary cells and tissues by the Encyclopedia of DNA Elements (ENCODE) consortium provided evidence for the use of several hundreds of thousands of such elements in the human genome 16 , which greatly exceeds the number of genes that encode mRNAs or long intergenic noncoding RNAs (lincRNAs). This raised the question of how the correct subsets of enhancers are selected from the large repertoire of potential enhancers in each particula r cell type.
Here, we review recent findings on the selection and function of enhancers that specify cell identity and that underlie the distinctive responses of cells to intracellular and extracellular signals. We discuss the collaborative and hierarchical binding of transcription factors to DNA in the context of chromatin, which orchestrates enhancer selection and priming, and the transformation of chromatin from a silent, primed or poised state to one that actively supports transcription. We conclude with a discussion of the 3D organization of enhancers in the nucleus and its importance for their function.
Enhancer characteristics
Genomic regions that function as transcriptional enhancers are enriched in closely spaced recognition motifs for sequence-specific transcription factors. Enhancer activation begins with the binding of transcription factors and local nucleosome remodelling. Recent genome-wide studies of nucleosome remodelling during differentiation of embryonic stem cells (ESCs) 
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Primed enhancers
Enhancers that have been selected by lineage-determining transcription factors and collaborating transcription factors. They are marked with characteristic histone modifications such as histone H3 lysine 4 monomethylation (H3K4me1) and H3K4me2, but do not produce enhancer RNAs.
and induced pluripotent stem cells indicated that the majority of remodelling affects a single nucleosome, and that alterations in nucleosome occupancy are more frequent at enhancers that are associated with pluripotency and differentiation 17 . Transcription factor binding leads to, and in some cases is facilitated by, the recruitment of co-regulators such as the histone acetyltransferase (HAT) p300 (REF. 18 ), followed by the recruitment of RNA polymerase II (Pol II) and the transcription of enhancer RNAs (eRNAs) 19, 20 . Co-regulator recruitment and transcription are accompanied by the covalent modification (methylation and acetylation, among others) of histone tails in enhancer-associated nucleosomes. In organisms with DNA methylation in the context of CG dinucleotides (that is, CpG methylation), these enhancers become demethylated upon their activation, concomitant with transcription factor binding 21 . Thus, epigenetic modification patterns can be used to distinguish between different enhancer activation states 22 and have been used extensively to annotate putative enhancer s in different cell types 16 . Enhancer states can broadly be classified as inactive, primed, poised or active 22 . An inactive enhancer is essentially buried in compact chromatin and is devoid of transcription factor binding and histone modifications. Primed enhancers are characterized by closely bound sequence-specific transcription factors that establish a DNase I-hypersensitive 15 and nucleosome-free 23 region of open chromatin. However, they may require additional cues to accomplish their function, which may include signal-dependent activation, the recruitment of additional transcription factors and the eventual recruitment of co-activators that lead to enhancer activation. Poised enhancers can be defined as primed enhancers that also contain repressive epigenetic chromatin marks (see below), a state that is most commonly found in ESCs. The characteristic features of poised and active enhancers are depicted in FIG. 1 .
An important insight for the identification of potential enhancers was the understanding that specific histone methylation signatures mark enhancer-like regions. In particular, enhancers display enrichment of histone H3 lysine 4 monomethylation (H3K4me1) or H3K4me2 and depletion of H3K4me3 compared with promoters 3 . Although genomic regions exhibiting these features are not necessarily functional enhancers, it seems that the vast majority of regions that do function as enhancers exhibit these characteristics 3, 7, 24 . Specifically, primed enhancer-like regions are marked with H3K4me1 and H3K4me2 and lack histone acetylation, and enhancer s marked additionally by H3K27me3, a repressive mark, are considered to be poised [24] [25] [26] (reviewed in REF. 27) (FIG. 1) . Features associated with active enhancers include H3K27 acetylation (H3K27ac) 25 and the presence of actively transcribing Pol II 19 . Examples of these features in the vicinity of the T-cell acute lymphocytic leukaemia 1 (TAL1) locus in the genomes of seven human cell lines, evaluated by the ENCODE consortium, are illustrated in FIG. 2 . Several developmental enhancers have been characterized for this locus: the −3.8-kb (upstream) and +19-kb (downstream) enhancers drive TAL1 transcription in human umbilical vein endothelial cells (HUVECs) and haematopoietic stem and progenitor cells 28, 29 , whereas the +51-kb enhancer is required for TAL1 expression in K562 erythroid cells 30 . DNase I hypersensitivity at this locus corresponds with overall transcription factor binding, and the presence of the active epigenetic marks H3K4me2 and H3K27ac is correlated with cell type-specific enhancer activity. Conversely, in cells that do not express TAL1, such as human ESCs and normal human epidermal keratinocytes, the +19-kb enhancer, promoter and gene body are devoid of DNase I-hypersensitive sites, and the -3.8-kb region and the gene body exhibit the repressiv e H3K27me3 mark. initiates nucleosome displacement to form narrow nucleosome-free regions at poised enhancers. The redundant histone methyltransferases myeloid/lymphoid or mixed-lineage leukaemia protein 3 (MLL3) and MLL4 deposit the active histone H3 lysine 4 monomethylation (H3K4me1) and H3K4me2 marks, whereas the histone-lysine N-methyltransferase EZH2 (a component of the Polycomb complex) deposits repressive H3K27me3 marks, and histone deacetylase (HDAC)-containing complexes maintain histones in a repressed, deacetylated state. RNA polymerase II (Pol II) is either absent or found at low levels at poised enhancers. b | In response to various cues, signal-dependent transcription factors (SDTFs) associate with recognition motifs in close association with LDTFs, which results in additional nucleosome displacement, as observed by widening of the DNase I-hypersensitive sites. SDTFs recruit co-activator complexes containing histone demethylase (HDM) complexes that remove H3K27me3 marks, histone acetyltransferases (HATs) that deposit H3K27 acetylation (H3K27ac) marks, and the Mediator complex (MED). The transformation to elongating Pol II results in bidirectional transcription -a hallmark of active enhancers -and the generation of enhancer RNAs (eRNAs), which is closely coupled to enhancer activity. 
PDZK1IP1 TAL1
Poised enhancers
Regulatory elements that are similar to primed enhancers but that are distinguished by the presence of histone H3 lysine 27 trimethylation (H3K27me3), which must be removed to allow the transition to an active enhancer state.
Active enhancers
Enhancers that are marked with histone H3 lysine 27 acetylation (H3K27ac) marks, in addition to the marks of poised enhancers. They produce enhancer RNAs, are bound by the Mediator complex and exert regulatory functions to increase the transcription of target genes.
Enhancer selection
The vast number of potential cis-regulatory elements in the genome and the cell type selectivity with which they are used raise the question of how unique enhancer repertoires are selected. Many lines of evidence indicate that enhancer selection is initially driven by 'pioneer' factors, exemplified by FOXA1 (also known as HNF3α), that are able to bind to their recognition motifs within the context of compacted chromatin 31 . By opening the conformation of the chromatin and initiating the process of enhancer selection, such pioneer factors can function as key cell lineage-determining transcription factors (LDTFs) to drive lineage-specific transcription programmes. However, most sequence-specific transcription Genomic features of a ~60-kb region of human chromosome 1 centred around the T-cell acute lymphocytic leukaemia 1 (TAL1) gene are shown. These include Encyclopedia of DNA Elements (ENCODE) consortium data of DNase I-hypersensitive (DNase HS) regions, as well as chromatin immunoprecipitation followed by sequencing (ChIP-seq) data of histone H3 lysine 4 dimethylation (H3K4me2), H3K27me3 and H3K27acetylation (H3K27ac) marks in seven cell lines. Enhancers that are known to be responsible for TAL1 transcription in endothelial cells (the -3.8-kb and +19-kb enhancers, relative to the TAL1 promoter, in human umbilical vein endothelial cells (HUVECs)) and in erythroid cells (the +51-kb enhancer in K562 cells) exhibit cell type-specific DNase I hypersensitivity, H3K4me2 and H3K27ac. In cell types in which TAL1 is not expressed, the promoter and gene body are devoid of DNase HS regions and histone modifications that are indicative of enhancer activation (H3K4me2 and H3K27ac), and they exhibit variable levels of the repressive H3K27me3 mark. Shaded boxes indicate cell type-restricted or cell type-specific enhancer regions. hESC, human embryonic stem cell; HSMM, human skeletal muscle myoblast; NHEK, normal human epidermal keratinocyte; NHLF, normal human lung fibroblast; PDZK1IP1, PDZK1-interacting protein 1.
Latent or de novo enhancer
An inactive enhancer that requires the binding of a combination of transcription factors, including signaldependent transcription factors, for selection.
factors, including those that function as pioneer factors, recognize fairly short DNA sequences (of approximately 6-12 bp in length), and their typical DNA recognition motifs exhibit varying levels of degeneracy. This means that most sequence-specific transcription factors have millions of potential binding sites in the mammalian genome. Nevertheless, chromatin immunoprecipitation followed by sequencing (ChIP-seq) experiments have indicated that they bind only to a small subset of all potential sites, and that a large fraction of the observed binding is associated with cell type-specific enhancers 32 . Cell type-specific binding sites often harbour motifs for additional pioneer factors, and experimental data strongly suggest that pioneer factors act in concert to jointly displace nucleosomes 33, 34 . Below, we review evidence that supports a model in which pioneer factors, or LDTFs, prime cell type-specifi c enhancers through collaborative interactions 7, 23, [35] [36] [37] [38] [39] [40] .
The role of lineage-determining transcription factors.
Experiments modulating the expression of LDTFs have demonstrated the ability of these factors to initiate the transition of enhancer elements from closed chromatin to a primed or poised state, in which transcription factors have gained access to the DNA and established nucleosom e-free regions 7, 10 (FIG. 1 ). An example is provided by the ETS domain transcription factor PU.1 (also known as SPI1), a LDTF required for the development of macrophages and B cells. PU.1 influences the establishment of distinct gene expression programmes in each cell type 41 . The vast majority of PU.1 binding sites are located >500 bp from promoters and mostly occupy different genomic locations in macrophages and B cells 7 . Macrophagespecific binding of PU.1 was observed at genomic locations that contained PU.1 binding sites in close proximity to binding sites of other macrophage LDTFs, such as the CCAAT/enhancer-binding proteins (C/EBPs) and activator protein 1 (AP1) factors. Conversely, B cellspecific binding of PU.1 was observed in close proximity to other B cell LDTFs, including motifs recognized by the transcription factor EBF1 (also known as COE1), the transcription factor E2α (E2A) and OCT factors. The corresponding motifs were generally situated <100 bp from the PU.1 motif, but most of these are not found at a close (5-20 bp) invariable distance that would be indicative of direct ternary protein-protein-DNA interactions 42 . Notably, macrophage-specific PU.1-bound regions were depleted of B-cell LDTF motifs, and vice versa, relative to adjacent genomic regions. This -together with the finding that in a given cell type, non-bound PU.1 motifs in transcriptionally inactive genomic regions are generally depleted of motifs of the LDTFs expressed in the cell 32 -suggests that LDTF motif composition may be one of the contributing factors to the formation of transcriptionally inactive and active genomic compartments (see below). Gain-and loss-of-function experiments revealed an interdependence of PU.1 with other LDTFs for effective DNA binding, which suggests that their collaborative interactions are necessary to compete with nucleosomes for binding to DNA. By considering natural genetic variation between inbred strains of mice as mutations, LDTF binding site mutations were found to impair not only binding of the respective LDTF but also that of closely bound LDTFs 43, 44 , which is consistent with a model in which enhancer selection is achieved through the collaborative efforts of multiple DNA-binding factors. Other examples of LDTF co operativity in establishing specific LDTF binding patterns have been observed in developmental systems, such as zebrafish haematopoiesis 45 and Drosophila m elanogaster embryogenesis 46 . The use of computational methods to identify binding motifs that are enriched in genomic regions marked by H3K4me1 resulted in the identification of LDTF motifs of the corresponding cell types. For example, binding sites for transcription factors that are capable of reprogramming fibroblasts into induced pluripotent stem cells are highly enriched in the H3K4me1-marked regions of the genome of ESCs 7 . Conversely, ChIP-seq studies commonly revealed that LTDFs occupy large fractions of the enhancers within the cells in which they exert lineage-determining functions 7, 10, 16, 36, 47, 48 . Thus, whereas most cells express hundreds of transcription factors, the selection of a large proportion of cell type-specific regulatory elements may be driven by fairly simple combinations of LDTFs that interact with each other and with other factors. Collectively, these findings may facilitate computational efforts to predict the selection of cell typespecific enhancer elements based on the local organization of binding motifs and the combinations of expressed transcriptio n factors.
The role of signal-dependent transcription factors.
Whereas LDTF binding may be sufficient for the activation of some enhancers, additional signals will be required for other enhancers to be fully activated. Many of the cellular responses to internal and external signals are dependent on the function of widely expressed, s ignal-dependent transcription factors (SDTFs). Examples of SDTFs are members of the nuclear receptor and NF-κB families. These factors frequently activate common sets of genes in different cell types but can also regulate gene expression in a cell type-specific manner. ChIP-seq studie s of SDTFs in different cell types found both common and cell type-specific binding sites 37, 38, 48 . Two types of mechanisms were suggested to account for cell type-specific binding of SDTFs. In one mechanism, such SDTF binding occurs at genomic locations that exhibit features of pre-selected enhancers 7, 36, 45 (FIG. 3a) . In these cases, there is a hierarchical relationship between SDTFs and LDTFs, with the latter acting as pioneer factors that are responsible for the initial enhancer selection through interactions with additional collaborating transcription factors (CTFs). In many cases, loss of function of the LDTF results in a failure of both the LDTF and the SDTF to bind to the enhancer, but loss of function of SDTFs does not result in a failure of LDTF binding 7, [48] [49] [50] [51] . Alternatively, SDTFs could contribute directly to latent or de novo enhancer selection 37, 50, 52 ( FIG. 3b) . This has been shown to involve collaborative interactions with LDTFs which, owing to their restricted cell type-specific expression patterns, impose cell typespecific enhancer selection at genomic locations that have the appropriate combination of motifs. Although the Nature Reviews | Molecular Cell Biology 
Locus control regions
Regions that confer tissue-specific expression to linked transgenes irrespective of the transgene integration site in the genome. These regions display characteristics of both enhancers and insulators.
mechanisms underlying collaborative DNA binding by transcription factors remain poorly understood, studies of the glucocorticoid receptor suggest that transcription factor binding can be highly dynamic, and that even two factors that interact with the same recognition motif in the same cell can facilitate each other's bindin g through a proposed assisted loading mechanism 53 . The extent to which SDTFs operate on poised enhancers or participate in de novo enhancer selection seems to vary depending on the factor, cell type and signal in question. Forkhead box protein P3 (FOXP3), a SDTF required for the acquisition of the T H 2 phenotype of CD4 + T cells, was found to bind almost exclusively to poised enhancers upon their activation 36 . By contrast, the receptor for the steroid hormone ecdysone, a member of the nuclear receptor family that mediates transcriptional responses to ecdysone in insects, primarily binds to newly selected enhancer elements in combination with cell type-specific transcription factors 37 . Both mechanisms of enhancer selection (FIG. 3) can occur simultaneously in the same cell type. For example, following macrophage activation by lipopolysaccharides, approximately 90% of the binding of the p65 subunit of NF-κB occurs at enhancers that are already primed, whereas the remainder is associated with the de novo selection of latent enhancers in collaboration with LDTFs, such as PU.1 and C/EBPα 43, 50 . Studies of different tissue macrophage populations demonstrate the importance of the environment for maintaining expression of cell type-specific transcription factors that in turn activate cell-specific enhancer programmes 54, 55 . These programmes arise from a combination of de novo enhancer selection by collaborative interactions involvin g cell-restricted transcription factors, as well as from the activation of poised enhancers by cell-restricted transcription factors 54 . Of note, the histone methylation signature of latent enhancers persists after the cessation of cell stimulation and is associated with more-rapid and morediverse transcriptional responses to subsequent stimulation 52 . These observations provide evidence that the writing of the H3K4me1 signature in enhancers provide s a molecular 'memory' of prior activation. (FIG. 1) , which are deposited by transcription co-regulators that are recruited to enhancers and promoters by transcription factors. Transcription co-regulators include histone methyltransferases, such as the myeloid/lymphoid or mixed-lineage leukaemia (MLL) proteins 56 ; HATs such as p300 and CREB-binding protein (CBP) 57 ; histone de acetylases, which are components of co-repressors such as nuclear receptor corepressors (NCORs) and SMRT (REF. 5); and chromatin remodellers such as the transcription activato r BRG1 complex or the BRM-associated factor (BAF) complex (also known as the mammalian SWI/SNF complexes) 58, 59 and the Mediator complex 60 . Recruitment of co-regulators to a given enhancer is more frequent when more transcription factors are co-bound to that enhancer 7, 61 . Co-regulators are large proteins with multiple distinct interaction sites for transcription factors 18, 62, 63 and probably act as both facilitators and integrators of transcription factor binding and intracellular signals at enhancers, which is similar to their known roles at promoters 64 .
Enhancer activation
Enhancer transcription. The epigenetic marks deposited by co-regulator complexes act as binding sites for chromatin 'readers' such as TFIID 65 and the bromodomaincontaining protein 4 (BRD4)-positive transcription elongation factor-b (P-TEFb) complex 66 , which function in transcription pre-initiation complex assembly and in transcription elongation, respectively.
The presence of the transcription pre-initiation complex and elongation factors at enhancers 67, 68 is in line with the finding that Pol II is found at enhancers. More than 20 years ago Pol II was observed to generate non-coding RNAs at locus control regions 69 , but it was only recently appreciated that mammalian enhancers are broadly transcribed and generate eRNAs 19, 20, [70] [71] [72] . Pol II recruitment to enhancers and signalling-dependent changes in Prior to signal-dependent activation, such regions may be poised enhancers or exhibit basal enhancer activity (that is, they are pre-existing enhancers) that is further induced by the binding of a SDTF. The resulting transcription is cell type-specific because the enhancers are selected by the cell type-specific LDTFs. b | SDTFs can direct the selection of latent or de novo enhancers. In these cases, the SDTF functions as an essential CTF to LDTFs to enable concurrent binding of all factors involved. The transcriptional output is cell type-specific because of the requirement for cell type-specific LDTFs for enhancer priming. H3K27ac, histone H3 lysine 27 acetylation. eRNA expression are highly correlated with changes in the expression of nearby genes, which suggests a functional link between eRNA and gene expression 50, [73] [74] [75] . The distinguishing features of eRNAs are that most are short (<1 kb), are not subjected to polyadenylation or splicing 19, 20 and are rapidly degraded by the exosome 71 . Similarly to what has been shown for short promoter antisense transcripts 76 , these characteristics are probably caused by the lack of 5ʹ splice donors proximal to eRNA TSSs 71, 72 , which are prerequisites for splicing and promote elongation 77 , packaging into messenger ribonucleoprotein particles (mRNPs), polyadenylation and nuclear export 78 , all of which contribute to the stability of transcripts. As a side note, the fact that enhancers resemble promoters in almost every aspect, apart from the lack of proximal splice donors 71 and H3K4me3 marks 79 , suggests that stable mRNAs or lincRNAs could be created by simply introducing a splice donor downstream of an eRNA TSS 72 . This would be consistent with the ability of intronic enhancers to act as alternative promoters 80 and with the fact that 42% of all lincRNAs have only two exons (that is, a single splice donor downstream of a promoter), compared with merely 6% of codin g genes 81 .
Nature Reviews
The occurrence of global enhancer transcription in mammalian cells raises the question of its functional importance. Recent studies provide evidence that eRNAs contribute to local enhancer activity, potentially by facilitating enhancer-promoter interactions through chromatin looping, recruitment of cofactors such as the Mediator complex (reviewed in REF. 66) (FIG. 4a) and the release of the negative elongation factor complex 82 . So far, there is limited evidence for specific sequence features of eRNAs that could be necessary for their function, and not all eRNAs seem to contribute to enhancer function. To date, little attention has been directed at the possibility that the process of enhancer transcription itself (which is independent of the eRNA product) could influence enhancer activity. Pol II is a powerful nucleosome-remodelling machine 83 , and transcription initiated from an enhancer sequence may contribute to maintaining an open chromatin configuration that enables access of sequence-specific transcription factors. In addition, enhancer transcription may have an important role in contributing to the deposition of H3K4me1 and H3K4me2 marks at enhancers (FIG. 4b) . Genetic studies indicate that the D. melanogaster H3K4 methyltransferase Trithorax-related (Trr) and its mammalian homologues MLL3 and MLL4 play important parts in the deposition of these marks 84, 85 , but the mechanisms that recruit these enzymes and that determine the overall distribution of histone methylation remain poorly understood. Studies of newly selected or de novo enhancers in activated macrophages provided evidence that the methylation of H3K4, but not the acetylation of H3K27, required enhancer transcription and the presenc e of MLL3 and MLL4 (REF. 50) .
A model of enhancer activation based on time-resolved studies of transcription factor binding, eRNA transcription, H3K4 methylation and H3K27 acetylation at de novo enhancers, and on results of gain-and loss-of-function experiments 50 , is illustrated in FIG. 4b . Signal-dependent activation of NF-κB (which is composed of subunits Another potential role of eRNAs could be to mediate interactions with protein complexes that are required for transcription elongation, such as the Mediator complex. b | In activated macrophages, the nuclear factor-κB (NF-κB) subunits p50 and p65, which are signal-dependent transcription factors (SDTFs), and the lineage-determining transcription factor (LDTF) PU.1 collaboratively select de novo enhancers. The subsequent recruitment of histone acetyltransferases (HATs) results in histone acetylation, a mark that is subsequently bound by the bromodomai n-containing protein 4 (BRD4)-positive transcription elongation factor-b (P-TEFb) complex, which allows its cyclin-dependent kinase 9 (CDK9) component to phosphorylate the carboxy-terminal domain (CTD) of Pol II. The phosphorylated CTD acts as a docking site for the myeloid/lymphoid or mixed-lineage leukaemia protein 3 (MLL3) and MLL4 histone H3 lysine 4 (H3K4) methyltransferases, which are proposed to deposit H3K4 monomethylation (H3K4me1) and H3K4me2 marks during successive rounds of Pol II elongation. CTF, collaborating transcription factor; H3K27ac, H3K27 acetylation. Chromosome conformation capture (3C). A method to probe the higher-order structure of the genome by capturing and sequencing DNA sites that are spatially close to each other in the nucleus.
Topologically associated domains
(TADs). Largely self-interacting genomic domains of submegabase size that are further organized into multimegabase-sized structures called nuclear compartments. Genes within TADs are co-regulated, and their expression patterns are highly correlated. p50 and p65) results in its collaborative binding to the enhancer with PU.1 and the recruitment of co-activato r complexes that contain HATs. These events result in nucleosome remodelling, histone acetylation and the recruitment of Pol II. The conversion of Pol II from a paused form to an elongating form involves the BRD4-P-TEFb complex, which is recruited to at least some sites of transcription initiation by inter actions between BRD4 and acetylated histone H4. Cyclin-dependent kinase 9 (CDK9), a component of P-TEFb, phosphorylates the carboxy-terminal domain (CTD) of Pol II, which provides docking sites for MLL3 and MLL4. MLL3 and MLL4 progressively methylate H3K4 during successive rounds of transcription elongation. Consistent with this model is the distribution of H3K4me1 and H3K4me2, which was found to corre late with the extent of enhancer transcription and to be dependent on transcription elongation 50 . The generality of this model with respect to the mechanisms by which H3K4 methylation marks are established at other classes of enhancers, such as those that are selected during cellu lar differentiation, remains to be determined. For example, in contrast to the activation of de novo enhancers in the context of extra cellular signalling responses, studies of the distribution of H3K4me1 and H3K4me2 at cell type-specific enhancer s selected during muscle and adipocyte differentiation suggested that MLL complexes can interact directly with LDTFs such as C/ EBPβ and myoblast determination protein 1 (MYOD1) at cell type-specific enhancers, where MLL3 and MLL4 are also required for acetylation of H3K27 and for recruitmen t of the Mediator complex and Pol II 85 . The function of H3K4me1 and H3K4me2 marks remains an open question. As they are known to recruit histone-remodelling complexes 86 , they could conceivably contribute to keeping previously bound and modifie d enhancers open and accessible, which would help to explain the observation that previously activated latent enhancers are more rapidly re-activated by subsequent stimuli 52 .
Enhancer function
Promoter activation requires that many components of the transcriptional machinery come together in order to assemble the pre-initiation complex, initiate transcription, overcome Pol II pausing and eventually lead to productive transcription elongation. Through looping of the intervening DNA, enhancers are brought into close proximity of promoters and are thought to affect any or all of the aforementioned processes by increasing the local concentrations of the factors involved 87 (FIG. 4a) .
These factors include co-activator complexes such as the Mediator complex, which increases the loading of transcription factors onto promoters and enhancers 60 ; scaffold proteins, such as cohesin, that mediate stable and often cell type-specific promoter-enhancer interactions 60, 88 ; and factors that are involved in releasing paused Pol II and in the initiation of elongation, such as BRD4 (REF. 89 ). A major challenge in deciphering cell type-specifi c enhancer functions is connectin g active enhancers to their target genes in vivo.
Super-enhancers. On the basis of their epigenetic features and depending on the experimental methods used to define enhancers, ~10,000-50,000 putative enhancers can be identified in a given cell type 13, 16, 90 , which implies that there are more enhancers than expressed genes. Along the linear DNA molecule, enhancers are located non-uniformly with respect to genes, such that some genes are located in enhancer-rich regions of the genome, whereas others have few or no enhancers in their vicinity. Although a single enhancer is sufficient to activate the expression of a nearby gene 37 , high levels of cell type-specific and/ or signal-dependent gene expression are most frequently observed for genes located in enhancerrich regions of the genome, which is exemplified by the relationship between enhancer-rich locus control regions and the expression of the globin genes in erythroid cells 69 . Such enhancer-dense regions have recently been termed super-enhancers [91] [92] [93] . Super-enhancers were initially defined as large (tens of kilobases in length) genomic loci with an unusually high density of enhancer-associated marks, such as binding of the Mediator complex, relative to most other genomic loci 91, 92 . These regions can also be defined by highdensit y 91 and/or extended (>3 kb) 94 depositions of the histone mark H3K27ac. Using differences in the density of Mediator complex-binding sites or of H3K27ac marks to distinguish super-enhancers from regular enhancers, most cell types are found to have 300-500 superenhancer s 91 . A substantial fraction of super-enhancers and nearby genes are cell type-specific, and the gene sets that are associated with super-enhancers in a given cell type are highly enriched for the biological processes that define the identities of the cell types 91, 94 . For example, many of the genes encoding factors required for pluripotency and self-renewal of ESCs are located near ESCspecific super-enhancers 91 . Consistent with their tissue specificity, super-enhancers that are active in certain cell types are enriched for disease-associated alleles relevant to that cell type 91, 94 . Not surprisingly, the individual enhancers of cell type-specific super-enhancers are enriched for binding sites of the corresponding LDTFs 92 . Collectively, the specific set of super-enhancers within a particular cell type may provide a means of simplifying the problem of defining what are the quantitatively most important transcriptional programmes required for establishing cell identity, and the problem of identifying disease-relevant non-coding genetic variation.
3D chromatin interactions.
In the nucleus, the genome is organized and partitioned into functional compartments in 3D space 95 , and considerable effort is being directed at understanding enhancer function in the context of 3D chromatin interactions. One strategy is to identify the long-range looping interactions that involve enhancer elements using a variety of chromosom e conformatio n captur e (3C)-based techniques 96 . Genome-wide applications of these techniques to define the chromatin interactomes of human and mouse cells confirmed that the genome is divided into active and inactive compartments 96 . These are further organized into submegabasesized topologically associated domains (TADs) that
Chromatin hubs
Nuclear domains comprised of regulatory DNA elements (locus control regions, enhancers and promoters) and genes that enable correct gene expression. The smallest unit of a hub could be a topologically associated domain, and the largest could comprise an entire nuclear compartment.
correlate with regions of the genome that constrain the spread of heterochromatin and are relatively conserved across cell types 97 . Although the genome-wide resolution of such studies remains limited, the resulting chromatin connectivity maps suggest that only approximately 7% of the looping interactions are made between adjacent genes, which indicates that linear genomic adjacency is not necessarily a good predictor of long-range interactions 98 . In addition, promoters and distal enhancer elements are frequently engaged in multiple long-range interactions and form active chromatin hubs 98, 99 (FIG. 5) .
Whereas super-enhancers are identified along the linear DNA sequence by means of their high density of typical epigenomic features, it is clear that the enhancers within a super-enhancer form 3D interactions that are a feature of the folded genome in the nucleus 93 (FIG. 5) . Interestingly, studies of tumour necrosis factor-α (TNFα)-responsive enhancers in human fibroblasts indicated that they are already in contact with their target promoters before the activation of TNFα signalling 100 , which suggests that enhancer-promoter interactomes are already set up during development. This is consistent with data from D. melanogaster, which show that only 6% of spatial genome interactions change during early embryonic development 101 . It is not yet known when higher-order chromatin interactions are established during development, but it is likely to coincide with the occurrence of gap phases following the mid-blastula transition, which is accompanied by the establishment of a non-random nuclear chromatin conformation and the transcriptional activation of chromatin domains 102 . It is unclear how the 3D organization of the genome is determined; however, cohesin and the Mediator complex 60 -which are scaffold proteins of the replication machinery and the transcription machinery, respectively -are known to be involved in the formation of higher-order chromatin structures. As cohesin seems to be recruited to enhancers through clusters of LDTFs 103 , it is likely that both protein-protein interactions and the genomic sequence shape 3D genomic conformations, although this hypothesis still awaits experiment al confirmation.
Given that the conformation of the genome seems to be mostly fixed across developmental stages 101 , individual cells 104 , cell types 97 and signalling states 100 , it is tempting to speculate how enhancers work in the 3D space: promoters are known to also function as transcriptional enhancers with regard to the activation of promoters in their proximity 105 , and enhancers have sequence features that are identical to those found in promoters 71, 72 . Both are juxtaposed within TADs as part of linear superenhancer s 92 and are being brought into proximity by higher-order chromatin conformations 74 , which leads to the co-regulatio n of promoters and enhancers within a domain 74, 106 . Knocking out enhancers within a TAD shows that the loss of an enhancer often only leads to a graded reduction in expression 107, 108, 74 and in developmental dysregulation 109 of the associated gene, which suggests that, at least in some cases, enhancers work in an additive manner. The distribution of gene regulation among a multitude of enhancers -some of which are located linearly within or beyond neighbouring genes (in their 'shadow' , hence the term 'shadow enhancers' (REF. 110)) but are close in 3D space -is thought to increase robustness of the regulatory system to mutations 111 . Whereas the higher-order chromatin structure of genomic regions >1 Mb is invariant to a large extent, single loci can transition between inert and active chromosomal states, depending on their activation status, which leads to stable repression or to a state poised for transcription, respectively 112 . By contrast, inside TADs within these large-scale compartments, the chromatin structure of regions <100 kb does differ in a cell typespecific manner 100 , which implies that different regulatory regions within TADs can be dynamically juxtaposed in a stimulus-specific manner. In this way, genome topology could contribute to cell type-specific transcription programmes, which means that mapping the genomic topology and elucidating the mechanisms that govern the 3D structure of the genome will be important steps towards understanding how the genome functions.
Conclusions and perspective
Although initially described >30 years ago, we still do not have a clear understanding of the mechanisms by which enhancers regulate gene expression. However, the development of a plethora of methods for genome-wide mapping of diverse enhancer features, their functional relationship with promoters and their ultimate transcriptional outputs has resulted in a number of striking and unexpected discoveries, ranging from the identification of the great number of enhancers in metazoan genomes to the widespread production of eRNAs. The observation that >80% of disease-associated alleles identified by genome-wide association studies are found in non-coding regions of the genome 113 implies that they have yet unappreciated regulatory functions. Consistent with this finding, several studies have demonstrated an enrichment of disease-associated loci in cell type-specific regulatory regions, including in super-enhancers, of the corresponding disease-relevant cell types 91, [114] [115] [116] [117] , and a number of studies are beginning to document the direct effects of common variation in enhancer elements on enhancer states [118] [119] [120] , gene expression 117, 121, 122 and disease [123] [124] [125] [126] [127] . Beyond the simple annotation of regulatory regions in the genome, it is important to understand how cells select the full complement of enhancers that are required for maintaining their identities and functions. In essence, we would like to be able to read the genomic template and predict from the combination of active transcription factors the enhancers that will be functional in a cell type-specific manner. The principle of collaborative transcription factor interactions at closely spaced DNA recognition motifs provides a starting point for predicting genome-wide patterns of transcription factor binding that are required for enhancer selection. These predictions can be validated by mutating binding sites or by taking advantage of naturally occurring genetic variation. However, transcription factor binding maps are insufficient for predicting enhancer activity. The discovery that enhancer transcription is highly correlated with nearby gene expression is likely to be an important clue in understanding how enhancers function. The evidence that eRNAs contribute to the activities of at least some enhancers provides momentum for determining their mechanisms of action. In addition, the importance of enhancer transcription itself in maintaining enhancer accessibility and contributing to enhancer-related H3K4 methyl ation requires further study, as the functional roles of H3K4 methylation, beyond providing a memory of prior enhancer activation, remain obscure 52 .
Defining functional enhancer-promoter inter actions remains an important goal. Despite being informative, chromatin connectivity maps do not directly relate chromatin interactions to the regulation of gene expression. Definitive evidence that a specific enhancer-like region exerts a transcriptional regulatory function requires the study of mutational effects on that region and, encouragingly, site-specific mutagenesis should The three successive concentric inner circles depict chromatin immunoprecipitation followed by sequencing (ChIP-seq) data of histone H3 lysine 27 acetylation (H3K27ac), the transcription factor PU.1 and the transcription repressor CCCTC-binding factor (CTCF), which is enriched at the boundaries of topologically associated domains (TADs). A region of high density of H3K27ac in the vicinity of the Atf3 gene is designated as a super-enhancer. Purple and black lines in the centre of the circle indicate physical contacts involving promoters and other genomic regions, respectively, as determined by significant genome-wide chromatin connectivity measurements using tethered conformation capture. This locus demonstrates the multitude of connections between the individual enhancers that constitute the Atf3 super-enhancer, which essentially forms its own TAD, as well as the longer-range enhancer-enhancer and enhancer-promoter interactions outside the TAD. Batf3; basic leucine zipper transcription factor, ATF-like 3; Mfsd7b, major facilitator superfamily domain-containing 7B; Nenf, neudesin neurotrophic factor; Nsl1, NSL1, MIND kinetochore complex component, homologue; Ppp2r5a, protein phosphatase 2, regulatory subunit B alpha; Tatdn3, TatD DNase domain-containing 3; Tmem206, transmembrane protein 206; Vash2, vasohibin 2.
be greatly facilitated by recently developed genome editing method s 128 . Such tools will enable us to systematically delete enhancer elements and modify enhancer sequences to evaluate chromatin connectivity and gene expression. As a complementary approach, recent studies have demonstrated the use of natural genetic variation as a tool to study the relationships between transcription factor binding, enhancer selection and the regulation of gene expression 43, 54 . Improving the understanding of the mechanisms underlying the selection and function of enhancers is likely to not only enable prediction of the consequences of genetic variation on gene expression and phenotype, but also provide approaches to directly alter enhancer function for therapeutic purposes.
